Miglioretti Diana L, Walker Rod, Weaver Donald L, Buist Diana S M, Taplin Stephen H, Carney Patricia A, Rosenberg Robert D, Dignan Mark B, Zhang Zhuo Tracy, White Emily
Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA.
Radiology. 2011 Feb;258(2):372-9. doi: 10.1148/radiol.10100974. Epub 2010 Dec 3.
To investigate sensitivity, specificity, and cancer detection rate of screening mammography according to week of menstrual cycle among premenopausal women.
In this institutional review board-approved HIPAA-compliant study, sensitivity, specificity, and cancer detection rate of 387,218 screening mammograms linked to 1283 breast cancers in premenopausal women according to week of menstrual cycle were studied by using prospectively collected information from the Breast Cancer Surveillance Consortium. Logistic regression analysis was used to test for differences in mammography performance according to week of menstrual cycle, adjusting for age and registry.
Overall, screening mammography performance did not differ according to week of menstrual cycle. However, when analyses were subdivided according to prior mammography, different patterns emerged. For the 66.6% of women who had undergone regular screening (mammography had been performed within the past 2 years), sensitivity was higher in week 1 (79.5%) than in subsequent weeks (week 2, 70.3%; week 3, 67.4%; week 4, 73.0%; P = .041). In the 17.8% of women who underwent mammography for the first time in this study, sensitivity tended to be lower during the follicular phase (week 1, 72.1%; week 2, 80.4%; week 3, 84.6%; week 4, 93.8%; P = .051). Sensitivity did not vary significantly by week in menstrual cycle in women who had undergone mammography more than 3 years earlier. There were no clinically meaningful differences in specificity or cancer detection rate.
Premenopausal women who undergo regular screening may benefit from higher sensitivity of mammography if they schedule screening mammography during the 1st week of their menstrual cycle.
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.10100974/-/DC1.
研究绝经前女性月经周期各周的乳腺钼靶筛查的敏感性、特异性及癌症检出率。
在这项经机构审查委员会批准且符合《健康保险流通与责任法案》(HIPAA)的研究中,利用从乳腺癌监测联盟前瞻性收集的信息,研究了387218例与1283例绝经前女性乳腺癌相关的乳腺钼靶筛查的敏感性、特异性及癌症检出率。采用逻辑回归分析来检验月经周期各周乳腺钼靶检查性能的差异,并对年龄和登记情况进行了校正。
总体而言,乳腺钼靶筛查性能在月经周期各周并无差异。然而,当根据既往乳腺钼靶检查情况进行细分分析时,出现了不同模式。对于66.6%进行过定期筛查(过去2年内进行过乳腺钼靶检查)的女性,第1周的敏感性(79.5%)高于随后几周(第2周,70.3%;第3周,67.4%;第4周,73.0%;P = 0.041)。在本研究中首次进行乳腺钼靶检查的17.8%的女性中,卵泡期的敏感性往往较低(第1周,72.1%;第2周,80.4%;第3周,84.6%;第4周,93.8%;P = 0.051)。对于3年多以前进行过乳腺钼靶检查的女性而言,月经周期各周的敏感性无显著差异。特异性或癌症检出率也没有临床意义上的差异。
进行定期筛查的绝经前女性,如果在月经周期的第1周安排乳腺钼靶筛查,可能会因钼靶检查更高的敏感性而受益。
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.10100974/-/DC1